共检索6条数据Total：6
2021-09-07
Department of Psychology, Southwest University, Chongqing, China.; Department of Psychology, Southwest University, Chongqing, China.; Department of Medcine, Yan'an University, Yan'an, China.; Department of Psychology, Southwest University, Chongqing, China.; Department of Psychology, Southwest University, Chongqing, China.
Background: The novel 2019 coronavirus disease (COVID-19) pandemic has spread rapidly worldwide and poses a global health threat. Aims: This study assessed the prevalence of anxiety and depression symptoms in Chinese students during the COVID-19 pandemic and explored potential moderating factors. Methods: We searched English and Chinese databases using pertinent keywords for articles published and unpublished, up until November 2020. The estimate of the overall prevalence of anxiety and depression was conducted through a random-effects model. Results: A total of 31 cross-sectional studies were included. The overall prevalence of anxiety and depression symptoms in Chinese students during the COVID-19 pandemic was 24.0% (95% CI [20.0-29.0%]) and 22.0% (95% CI [18.0-27.0%]) respectively. Subgroup analyses revealed that Chinese middle school students were at heightened risk of anxiety, while university students were at heightened risk of depression. Students who lived in higher-risk areas
2020-04-01
grid.260987.20000 0001 2181 583XResource and Environment Department, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XWestern Ecology Research Center, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XResource and Environment Department, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XResource and Environment Department, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XResource and Environment Department, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XWestern Ecology Research Center, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XWestern Ecology Research Center, Ningxia; University, Yinchun, 750021 China
Endemic fluorosis is widespread in China, especially in the arid and semi-arid areas of northwest China, where endemic fluorosis caused by consumption of drinking water high in fluorine content is very common. We analyzed data on endemic fluorosis collected in Ningxia, a typical high-fluorine area in the north of China. Fluorosis cases were identified in 539 villages in 1981, in 4449 villages in 2010, and in 3269 villages in 2017. These were located in 19 administrative counties. In 2017, a total of 1.07 million individuals suffered from fluorosis in Ningxia, with more children suffering from dental fluorosis and skeletal fluorosis. Among Qingshuihe River basin disease areas, the high incidence of endemic fluorosis is in Yuanzhou District and Xiji County of Guyuan City. The paper holds that the genesis of the high incidence of endemic fluorosis in Qingshui River basin is mainly caused by chemical weathering, evaporation and
2020-04-01
grid.260987.20000 0001 2181 583XResource and Environment Department, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XWestern Ecology Research Center, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XResource and Environment Department, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XResource and Environment Department, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XResource and Environment Department, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XWestern Ecology Research Center, Ningxia; University, Yinchun, 750021 China grid.260987.20000 0001 2181 583XWestern Ecology Research Center, Ningxia; University, Yinchun, 750021 China
Endemic fluorosis is widespread in China, especially in the arid and semi-arid areas of northwest China, where endemic fluorosis caused by consumption of drinking water high in fluorine content is very common. We analyzed data on endemic fluorosis collected in Ningxia, a typical high-fluorine area in the north of China. Fluorosis cases were identified in 539 villages in 1981, in 4449 villages in 2010, and in 3269 villages in 2017. These were located in 19 administrative counties. In 2017, a total of 1.07 million individuals suffered from fluorosis in Ningxia, with more children suffering from dental fluorosis and skeletal fluorosis. Among Qingshuihe River basin disease areas, the high incidence of endemic fluorosis is in Yuanzhou District and Xiji County of Guyuan City. The paper holds that the genesis of the high incidence of endemic fluorosis in Qingshui River basin is mainly caused by chemical weathering, evaporation and
2020-03-26
Department of Disease Control and Prevention, General Hospital of Central Theater; Command, 430015 Wuhan, Hubei province People’s Republic of China Department of Disease Control and Prevention, General Hospital of Central Theater; Command, 430015 Wuhan, Hubei province People’s Republic of China Department of Disease Control and Prevention, General Hospital of Central Theater; Command, 430015 Wuhan, Hubei province People’s Republic of China Department of Laboratory, General Hospital of Central Theater Command, 430015; Wuhan, Hubei province People’s Republic of China Department of Laboratory, General Hospital of Central Theater Command, 430015; Wuhan, Hubei province People’s Republic of China MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, CB2 ; 0QH UK Department of Disease Control and Prevention, General Hospital of Central Theater; Command, 430015 Wuhan, Hubei province People’s Republic of China 0000 0004 1760 6682grid.410570.7Department of Biochemistry and Molecular Biology,; Third Military Medical University (Army Medical University), 400038 Chongqing, People’s Republic of China
2020-03-26
Department of Disease Control and Prevention, General Hospital of Central Theater; Command, 430015 Wuhan, Hubei province People’s Republic of China Department of Disease Control and Prevention, General Hospital of Central Theater; Command, 430015 Wuhan, Hubei province People’s Republic of China Department of Disease Control and Prevention, General Hospital of Central Theater; Command, 430015 Wuhan, Hubei province People’s Republic of China Department of Laboratory, General Hospital of Central Theater Command, 430015; Wuhan, Hubei province People’s Republic of China Department of Laboratory, General Hospital of Central Theater Command, 430015; Wuhan, Hubei province People’s Republic of China MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, CB2 ; 0QH UK Department of Disease Control and Prevention, General Hospital of Central Theater; Command, 430015 Wuhan, Hubei province People’s Republic of China 0000 0004 1760 6682grid.410570.7Department of Biochemistry and Molecular Biology,; Third Military Medical University (Army Medical University), 400038 Chongqing, People’s Republic of China
2021-10-05
Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Department of General Surgery, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Wuhan Huoshenshan Hospital, Wuhan, China.; Wuhan Huoshenshan Hospital, Wuhan, China.; Department of Orthopedics, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Wuhan Huoshenshan Hospital, Wuhan, China.; Pulmonary and critical care medicine center, Chinese PLA Respiratory Disease Institute, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Wuhan Huoshenshan Hospital, Wuhan, China.; Institute of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Wuhan Huoshenshan Hospital, Wuhan, China.; Institute of Cancer, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Department of Biochemistry and Molecular Biology, Third Military Medical University (Army Medical University), Chongqing, China.; Institute of Infection and Immunology, University of London, London, United Kingdom.; Department of Epidemiology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing, China.; Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Wuhan Huoshenshan Hospital, Wuhan, China.; Department of Medical and Research Management, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Wuhan Taikang Tongji Hospital, Wuhan, China.; Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Wuhan Huoshenshan Hospital, Wuhan, China.
IMPORTANCE: The long-term health outcomes and symptom burden of COVID-19 remain largely unclear. OBJECTIVE: To evaluate health outcomes of COVID-19 survivors 1 year after hospital discharge and to identify associated risk factors. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, multicenter cohort study was conducted at 2 designated hospitals, Huoshenshan Hospital and Taikang Tongji Hospital, both in Wuhan, China. All adult patients with COVID-19 discharged between February 12 and April 10, 2020, were screened for eligibility. Of a consecutive sample of 3988 discharged patients, 1555 were excluded (796 declined to participate and 759 were unable to be contacted) and the remaining 2433 patients were enrolled. All patients were interviewed via telephone from March 1 to March 20, 2021. Statistical analysis was performed from March 28 to April 18, 2021. EXPOSURES: COVID-19. MAIN OUTCOMES AND MEASURES: All patients participated in telephone interviews using a series of questionnaires